Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Sell Stocks for August 6th


Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

AC Immune ACIU is a biopharmaceutical company which develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Zacks Consensus Estimate for its current year earnings has been revised 12.1% downward over the last 60 days.

Ambev ABEV is engaged in producing, distributing and selling beer, carbonated soft drinks and other non-alcoholic and non-carbonated products in many countries across the Americas. The Zacks Consensus Estimate for its current year earnings has been revised 5.6% downward over the last 60 days.

Alexander's ALX is a real estate investment trust engaged in leasing, managing, developing and redeveloping properties. The Zacks Consensus Estimate for its current year earnings has been revised almost 5.5% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ambev S.A. (ABEV): Free Stock Analysis Report
 
AC Immune (ACIU): Free Stock Analysis Report
 
Alexander's, Inc. (ALX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Share
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments